Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.311
Neutral
RSI(14)
46.939
Neutral
STOCH(KDJ)(9,3,3)
72.659
Buy
ATR(14)
1.354
Low Volatility
CCI(14)
97.841
Neutral
Williams %R
17.057
Overbought
TRIX(12,20)
-0.365
Sell
StochRSI(14)
100.000
Buy
Conmed Corp
CNMD40.770USD
+0.600+1.49%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
19.71P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Conmed Corp
Currency: USD Updated: 2025-12-26Key Insights
Conmed Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 39/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 50.20.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Conmed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Hold
Current Rating
50.200
Target Price
+23.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Conmed Corp Highlights
StrengthsRisks
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 25.02% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 18.63%.
Fairly Valued
The company’s latest PE is 19.73, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 36.30M shares, increasing 0.00% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 18.13K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-26The current financial score of Conmed Corp is 8.28, ranking 49/207 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 337.93M, representing a year-over-year increase of 6.70%, while its net profit experienced a year-over-year increase of 94.16%.
Score
Financials
5.67
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
8.90
Growth Potential
7.61
Shareholder Returns
9.22
Conmed Corp's Company Valuation
Currency: USD Updated: 2025-12-26The current valuation score of Conmed Corp is 8.23, ranking 37/207 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 19.73, which is 202.63% below the recent high of 59.70 and 320.75% above the recent low of -43.55.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 39/207
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-26The current earnings forecast score of Conmed Corp is 6.33, ranking 172/207 in the Healthcare Equipment & Supplies industry. The average price target for Conmed Corp is 52.00, with a high of 55.00 and a low of 41.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
50.200
Target Price
+23.74%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
62
Total
5
Median
6
Average
Company name
Ratings
Analysts
Conmed Corp
CNMD
6
Apple Inc
AAPL
50
Ge Vernova Inc
GEV
34
FMC Corp
FMC
21
Tapestry Inc
TPR
21
Verisk Analytics Inc
VRSK
20
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-26The current price momentum score of Conmed Corp is 6.58, ranking 124/207 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 44.77 and the support level at 37.57, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
40.120
Buy
MA10
40.114
Buy
MA20
41.010
Sell
MA50
43.192
Sell
MA100
47.010
Sell
MA200
50.790
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-26The current institutional shareholding score of Conmed Corp is 10.00, ranking 1/207 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 136.51%, representing a quarter-over-quarter decrease of 0.59%. The largest institutional shareholder is The Vanguard, holding a total of 3.60M shares, representing 11.63% of shares outstanding, with 2.83% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
EARNEST Partners, LLC
Fuller & Thaler Asset Management Inc.
Westwood Management Corp. (Texas)
Dimensional Fund Advisors, L.P.
State Street Investment Management (US)
Managed Account Advisors LLC
Silvercrest Asset Management Group LLC
Capital Research Global Investors
1
2
Risk Assessment
Currency: USD Updated: 2025-12-26The current risk assessment score of Conmed Corp is 6.69, ranking 54/207 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.96. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.96
VaR
+4.01%
240-Day Maximum Drawdown
+47.31%
240-Day Volatility
+44.31%
Return
Best Daily Return
60 days
+5.73%
120 days
+5.73%
5 years
+16.45%
Worst Daily Return
60 days
-9.43%
120 days
-9.43%
5 years
-12.38%
Sharpe Ratio
60 days
-1.31
120 days
-1.09
5 years
-0.40
Risk Assessment
Maximum Drawdown
240 days
+47.31%
3 years
+71.41%
5 years
+75.17%
Return-to-Drawdown Ratio
240 days
-0.87
3 years
-0.27
5 years
-0.18
Skewness
240 days
+0.74
3 years
+0.09
5 years
+0.03
Volatility
Realised Volatility
240 days
+44.31%
5 years
+39.35%
Standardised True Range
240 days
+5.03%
5 years
+7.66%
Downside Risk-Adjusted Return
120 days
-153.23%
240 days
-153.23%
Maximum Daily Upside Volatility
60 days
+25.58%
Maximum Daily Downside Volatility
60 days
+31.85%
Liquidity
Average Turnover Rate
60 days
+1.50%
120 days
+1.50%
5 years
--
Turnover Deviation
20 days
-3.11%
60 days
-0.32%
120 days
-0.02%
Peer Comparison
Healthcare Equipment & Supplies
Conmed Corp
CNMD
7.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Conmed Corp?
The TradingKey Stock Score provides a comprehensive assessment of Conmed Corp based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Conmed Corp’s performance and outlook.
How do we generate the financial health score of Conmed Corp?
To generate the financial health score of Conmed Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Conmed Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Conmed Corp.
How do we generate the company valuation score of Conmed Corp?
To generate the company valuation score of Conmed Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Conmed Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Conmed Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Conmed Corp.
How do we generate the earnings forecast score of Conmed Corp?
To calculate the earnings forecast score of Conmed Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Conmed Corp’s future.
How do we generate the price momentum score of Conmed Corp?
When generating the price momentum score for Conmed Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Conmed Corp’s prices. A higher score indicates a more stable short-term price trend for Conmed Corp.
How do we generate the institutional confidence score of Conmed Corp?
To generate the institutional confidence score of Conmed Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Conmed Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Conmed Corp.
How do we generate the risk management score of Conmed Corp?
To assess the risk management score of Conmed Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Conmed Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Conmed Corp.
